Adipo LABs’ practice of ‘humanity’ that transcends borders

【Health and Welfare News】 AdipoLABs (CEO Han Sung-ho), which develops, produces, and sells a high-frequency hyperthermia device called ‘REMISSION 1℃’ continues to practice love for humanity beyond borders.

AdipoLABs, which donated REMISSION 1℃ to Angola for free in November last year, donated another device to the Republic of Cameroon for the treatment of COVID-19.

▲ From the left, Jeff Anoh T.Z, representative of the community in Cameroon, Park Yong-mook, Vice Consul of the Cameroon Honorary Consulate in Korea, Han Sung-ho, CEO of AdipoLABs, and Kim Jin-soo, former Commissioner of the Korea Food and Drug Administration.

At the donation ceremony held at the AdipoLABs office on the 2nd, Vice Consul Park Yong-mook of the Cameroon Honorary Consulate in Korea attended on behalf of the Cameroon government, along with Jeff Anoh T.Z., representative of the Cameroonian community, AdipoLABs CEO Han Sung-ho, and former advisor to the Minister of Food and Drug Safety Kim Jin-soo.

At the donation ceremony on this day, former Minister of Food and Drug Safety Kim Jin-soo said, “Pandemic situations such as COVID-19 are not limited to one country and can start again at any time,” and added, “We confirmed the possibility of immunotherapy through high-frequency hyperthermia therapy rather than existing diagnosis and vaccine methods, and the whole world including our country can be safe from disease.”

Next, Angola Vice Consul to Korea Park Yong-mook said, “We are grateful to IVRA and AdipoLABs CEO Han Sung-ho for donating this wonderful high-frequency hyperthermia device. On behalf of the people of Cameroon, I would like to express my gratitude. I hope that today’s donation ceremony will become a touchstone for enhancing cooperation between two countries, and that we will share the results of patient treatment and finally help more people overcome COVID-19.”

AdipoLABs is providing a humanitarian medical care to IVRA (International Virus Research Cooperation) member countries suffering from COVID-19 as its Remission 1℃, a medical high-frequency hyperthermia cancer treatment device that can relieve pain and treat cancer, has been shown to be effective in immunotherapy. The equipment is being donated free of charge.

In particular, AdipoLABs' high frequency hyperthermia therapy device REMISSION 1℃, which is supplied to the Catholic University of Korea's Seoul St. Mary's Hospital as well as Gangnam Severance Hospital and many other cancer treatment wards and nursing hospitals, is attracting attention as an immunotherapy device for the treatment of COVID-19. As part of international medical sharing through IVRA, the company AdipoLABs is working hard to provide overseas medical support.

▲ AdipoLabs’ ‘High Frequency Hyperthermia Device REMISSION 1℃’

AdipoLABs’ high frequency hyperthermia device called REMISSION 1℃ raises our body temperature above 40℃ through high frequency waves, increasing deep heat and therefore resulting in a necrosis of heat-vulnerable cancer cells while promoting blood circulation and activating autoimmune cells.

Based on this, REMISSION 1℃ not only treats cancer but also relieves pain. The device was certified as an official medical device by the Ministry of Food and Drug Safety in 2015, stealing the limelight of major domestic and international exhibitions and medical officials.

IVRA was started with the belief that we can catch COVID-19, a viral disease, based on the medical community's judgment that when deep core fever occurs through high frequency, the NK Cell, an autoimmune cell in our body, is activated to the highest level of the test value and can eradicate the virus.

Viruses cannot endure heat, so the medical officials believe that activating immunity through heat can shorten treatment time and lock widespread disease under control.

As a matter of fact, through the donation of high-frequency hyperthermia device REMISSION 1°C provided by AdipoLABs for each country, we have achieved results in treating viral diseases by increasing the patient's autoimmunity. By sharing this data with each other between countries, we can protect ourselves even if the second COVID-19 breaks out. The device is expected to play a major role in speeding the recovery to daily life and ending the pandemic.

CEO Han Sung-ho said, “Through support policies for each country, we hope that the high-frequency hyperthermia device REMISSION 1℃ will serve as an opportunity to prove the effectiveness of immunotherapy for many patients infected with the virus and at the same time we would like to contribute to cancer treatment and help those patients in pain.”

He also added, “The high-frequency hyperthermia device REMISSION 1°C is easy to operate and has no grave side effects, so anyone with medical expertise can use it easily. The plan to provide free support to IVRA member countries will continue in the future.”

Meanwhile, the International Virus Research Alliance (IVRA), an international virus research collaboration, was hosted by the International Medical Sharing Foundation at the COEX conference room on September 29th last year, with leading overseas medical officials and government officials from each country joining together via LAN cable to discuss the COVID-19 pandemic. We held an international conference to lead the era of With COVID-19 and presented a new medical paradigm centered on the possibility of 'immune treatment'.

At this event, AdipoLABs, an IVRA partner, provided free support to member government authorities in case any member wishes to receive the high-frequency hyperthermia device REMISSION 1℃. The company shared treatment data including cases based on treatment protocols and willing to collaborate with international medical experts. AdipoLABs has announced a plan to provide free medical equipment in order to continue research together.

Accordingly, inquiries and consultations were made from IVRA member countries, and this donation ceremony was held at the official request of the Cameroon government, following Angola in Africa.

link: http://m.whosaeng.com/135794